2021
DOI: 10.1002/msc.1561
|View full text |Cite
|
Sign up to set email alerts
|

Impact of the COVID‐19 pandemic on recruitment to clinical research studies in rheumatology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
24
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 30 publications
(27 citation statements)
references
References 18 publications
1
24
0
1
Order By: Relevance
“…We also note the relatively low proportions of CARE participants who self‐reported ADRD (9.4%) or are caregivers (11.0%, including caregivers for someone with ADRD). The COVID‐19 pandemic likely exacerbated existing barriers to research recruitment 47,48 . On the ground, the pandemic has resulted in fewer in‐person outreach and recruitment activities where we can interact directly in real time with individuals interested in CARE.…”
Section: Discussionmentioning
confidence: 99%
“…We also note the relatively low proportions of CARE participants who self‐reported ADRD (9.4%) or are caregivers (11.0%, including caregivers for someone with ADRD). The COVID‐19 pandemic likely exacerbated existing barriers to research recruitment 47,48 . On the ground, the pandemic has resulted in fewer in‐person outreach and recruitment activities where we can interact directly in real time with individuals interested in CARE.…”
Section: Discussionmentioning
confidence: 99%
“…We believe the low recruitment rate resulted from the effects of the COVID-19 pandemic on patient participation in the clinic. Previous studies [17][18][19] have examined the difficulties resulting from the pandemic on clinic trial recruitment. In addition, there appears to be a Hawthorne effect for our study cohort.…”
Section: Discussionmentioning
confidence: 99%
“…It is reported by several authors that the willingness to participate in clinical trials during COVID-19 pandemic decreased up to 10–20%; some were closed because of insufficient sample sizes. 35 36 Nevertheless, further investigations of the remaining families of our cohort are to be implemented. An additional limitation of our study is that we have not yet been able to reclassify novel genetic variants; therefore, we need future functional experiments of candidate genes in vitro.…”
Section: Discussionmentioning
confidence: 99%